Skip to main content
MTEX
NASDAQ Life Sciences

Mannatech CFO to Depart in June; Controller Appointed Interim CFO

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Household Product Stocks · Consumer
Sentiment info
Negative
Importance info
7
Price
$6.86
Mkt Cap
$13.04M
52W Low
$6.14
52W High
$12.454
52W Position info
12% above low
Off High info
45% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

MTEX is trading near its 52-week low of $6.14 (12% above the low) on light trading volume (0.2× avg).

Summary

Mannatech announced that its CFO, James Clavijo, will not have his employment agreement renewed, with his term ending on June 30, 2026. The company has appointed Yasir Haider, the current Controller, as Interim CFO to manage the transition.


Key Events · Executive and Board Changes · MTEX

  • CFO Employment Not Renewed

    James Clavijo's employment agreement as Chief Financial Officer will not be renewed, with his term expiring on June 30, 2026.

  • Interim CFO Appointed

    Yasir Haider, the Company's Controller, has been appointed Interim CFO effective March 20, 2026, to facilitate the transition.

  • Transition Compensation

    Mr. Clavijo is entitled to receive his base salary for three months following the expiration of his current term.


Analysis · MTEX · Life Sciences

The departure of a Chief Financial Officer introduces uncertainty, particularly for a micro-cap company like Mannatech. However, the planned nature of Mr. Clavijo's departure, with his employment agreement expiring in June, and the appointment of an internal, experienced Controller as Interim CFO, suggests a managed transition rather than an abrupt crisis. Investors should monitor the company's financial reporting and any further announcements regarding a permanent CFO appointment.

How filings like this one have moved

In the 30 days to Oct 4, 2026, 29.2% of the 1581 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.60%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MTEX was trading at $6.86 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $13M. The 52-week trading range was $6.14 to $12.45. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MTEX - Latest Insights

MTEX
Aug 12, 2026, 4:03 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $5.07
Real-time Price: $6.64 info
Change: +$1.57 (+31%) info
Market Cap: $12.813M info
MTEX
Aug 12, 2026, 4:02 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $5.07
Real-time Price: $6.64 info
Change: +$1.57 (+31%) info
Market Cap: $12.813M info
MTEX
Jun 08, 2026, 4:03 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.63
Real-time Price: $6.64 info
Change: +$1.01 (+18%) info
Market Cap: $12.813M info
MTEX
May 20, 2026, 2:37 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $3.98
Real-time Price: $6.64 info
Change: +$2.66 (+67%) info
Market Cap: $12.813M info
MTEX
May 14, 2026, 4:11 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $4.62
Real-time Price: $6.64 info
Change: +$2.02 (+44%) info
Market Cap: $12.813M info